Genpro Research today announced the appointment of Steve Herbert as Chief Commercial Officer of Genpro Research Inc., leading the commercial, BD and sales strategy. He will be based out of company’s Boston office.
Mr. Herbert brings over 20 years of commercial leadership and expertise in the US & European Clinical Research & Pharmaceutical software markets as well as an in-depth knowledge of the pharmaceutical industry.
Steve was raised in London, graduated in Biology (Hons.) from York University, UK.
”Steve’s appointment demonstrates the continued commitment of Genpro Research to expanding the scope and reach of our products and services to our global customers,” said Anoop Ambika, Chief Executive Officer of Genpro Research. “Over the last 24 months, Genpro Research has been rapidly expanding and increasing its footprint in India and US. Steve’s wealth of experience in scaling small and medium enterprises in the US & European markets will greatly enhance our position internationally and provide the expertise and leadership that we need to serve our clients more effectively worldwide. Steve is a strong addition to the executive management team and an asset to our global strategy.”
About Genpro Research
Genpro Research is a next-generation services and technology partner for the pharmaceutical, biotechnology, and medical devices industry. Our tools use Artificial Intelligence, Machine Learning, and Natural Language Processing algorithms to enable automation of several processes in a drug development pipeline. We provide advanced solutions in Biostatistics & Programming, Medical Writing, and Regulatory Submissions. Genpro currently has a US office in Waltham, MA. We have offshore development centers in three cities in India – Thiruvananthapuram, Baroda, and Bangalore.